Serum anti-Jo-1 antibody level correlates with disease activity in polymyositis and dermatomyositis
10.3760/cma.j.issn.1007-7480.2011.11.005
- VernacularTitle:多发性肌炎和皮肌炎血清抗Jo-1抗体水平与疾病活动度相关性研究
- Author:
Yao XIE
;
Xiaoming SHU
;
Xin LU
;
Guochun WANG
- Publication Type:Journal Article
- Keywords:
Polymyositis;
Dermatomyositis;
Enzyme-linked immunosorbent assay;
Anti-Jo-1antibody
- From:
Chinese Journal of Rheumatology
2011;15(11):742-745
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo evaluate the correlation between serum anti-Jo-1 antibody level and myositis disease activity in polymyositis/dermatomyositis.MethodsAnti-Jo-1 antibody levels in serum from 148 polymyositis/dermatomyositis patients and 130 healthy controls were measured by both ELISA and immunoblot assay.Disease activity of the anti-Jo-1 antibody positive patients was assessed by the global myositis disease activity score (visual analogue score,VAS) established by the International Myositis Assessment and Clinical Studies(IMACS) Group.The correlation between disease activity and level of serum antiJo-1 antibody was assessed.Comparisons between groups were performed by x2 test or t test.ResultsThe positive rate of ELISA and EUROLINE was 24.3％(36/148) and 27.0％(40/148) respectively.Fever,ILD,arthritis/arthralgia were found to be more predominant in anti-Jo-1 antibody positive patients than those who were anti-Jo-1 antibody negative patients.There was significant positive correlation between the global myositis disease activity score (VAS) and serum level of anti-Jo-1 antibody (r=0.874,P=9.000).Serum antiJo-1 antibody levels,together with global disease activity,were significantly decreased in the 7 patients after treatment.ConclusionAnti-Jo-1 antibody level measured by ELISA is associated with disease activity of PM/DM,and could be a marker of disease activity.
